Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

IOU Financial Inc. Releases Financial Results for the Three and Nine-Month Period Ended September 30, 2019 and Provides Corporate Update

Published

on

IOU FINANCIAL INC. (“IOU” or “the Company”) (TSXV: IOU), a leading online lender to small businesses (IOUFinancial.com), announced today its results for the three and nine-month period ended September 30, 2019.

“We continue to execute on our strategy of profitable growth given strong loan origination and revenue performance in the third quarter of 2019. This represents the Company’s seventh consecutive quarter of positive earnings” said Phil Marleau, CEO.

FINANCIAL HIGHLIGHTS

  • Please refer to the table below for adjustments made to IFRS gross revenue and operating expenses in order to better reflect the actual operating performance of the business.
  • In the third quarter of 2019, the Company funded US$41.4 million in loans (2018: US $36.1 million), representing an increase of 14.5% over Q3 2018. During the nine-month period ended September 30, 2019, the Company funded $112.7 million in loans (2018: US $89.9 million), representing an increase of 25.4% over the same period last year. This was driven by the introduction of new loan products, geographic expansion into Canada as well as the addition of several new strategic partnerships in line with the Company’s growth strategy. This was in line with the Company’s long-term outlook for annual loan origination growth of 25% to 30%.
  • As at­ September 30, 2019, total loans under management amounted to $108.0 million (2018: $84.7 million), representing an increase of 27.4% year over year and is attributable to the growth in loan originations of 25.4% in the first nine months of 2019 compared to the same period in 2018. The principal balance of the loan portfolio amounted to $54.5 million (2018: $30.2 million), representing an increase of 80.5% and consistent with the Company’s strategy to retain more loans on its balance sheet. The principal balance of IOU Financial’s servicing portfolio (loans being serviced on behalf of third parties) amounted to $53.4 million (2018: $54.5 million), representing a decrease of 2.0%.
  • Adjusted gross revenue increased 46.8% to $6.8 million for the three-month period ended September 30, 2019 compared to Q3 2018 ($4.6 million) due to an increase in interest revenue and servicing income.
  • Interest revenue increased 58.7% to $5.2 million in Q3 2019 compared to the same period in 2018 as a result of the increase in the average commercial loans receivable balance of 67.5% in Q3 2019 compared to Q3 2018. The increase in the interest revenue will lag behind the increase in the average commercial loans receivable balance as loans originated in the latter part of the quarter do not contribute interest revenue for the full quarter. In addition to the timing of the loan origination, other factors can impact the calculation of the portfolio yield such as the number of business days in the period and currency translation.
  • Servicing income increased 21.4% to $1.2 million in Q3 2019 compared to Q3 2018 as a result of the increase in the average servicing portfolio of 9.5% in Q3 2019 compared to Q3 2018 as well as a 0.9 percentage point increase in the servicing portfolio yield from 8.1% in Q3 2018 to 9.0% in Q3 2019. Quicker payoffs and other factors have had a positive effect on the servicing portfolio yield.
  • Adjusted gross revenue increased to $17.4 million (2018: $13.3 million), representing an increase of 30.5% for the nine-month period ended September 30, 2019 compared to the same period in 2018.
  • Interest expense during the three-month period ended September 30, 2019 increased 24.3% to $1.1 million (2018: $0.9 million). The increase is attributable to an increase in average borrowings of 40.7% in Q3 2019 compared to Q3 2018 and offset by a 1.3 percentage point decrease in the Cost of Borrowing Rate to 10.4%. In an effort to lower its Cost of Borrowing Rate, the Company closed a new credit facility in the first quarter of 2019 at a rate which is substantially lower than the current Cost of Borrowing Rate. Specifically, the rate on the new credit facility was 6.64% at September 30, 2019 or approximately 3.8 percentage points less than the current Cost of Borrowing Rate. As the company continues to increase borrowings from the new credit facility, the overall Cost of Borrowing Rate is expected to drop in the future. Interest expense during the nine-month period ended September 30, 2019 increased to $2.9 million (2018: $2.5 million), an increase of 16.4% compared to the same period last year.
  • Provision for loan losses during the three-month period ended September 30, 2019 increased to $2.4 million (2018: $1.3 million). The increase is attributable to an increase in the average commercial loans receivable balance in the third quarter of 2019 of 67.5% compared to the same period last year and an increase in the Provisional Credit Loss Rate to 18.2% in Q3 2019 compared to 17.1% in Q3 2018 due to a slight increase in delinquencies related to loans originated in Q2 2019. The Company expects the Provisional Credit Loss Rate to vary from quarter to quarter. The Provisional Credit Loss Rate during the nine-month period ended September 30, 2019 was 17.0%. The Company expects the Provisional Credit Loss Rate to average approximately 16.5%. The Provisional Credit Loss Rate is a representation of the expected credit loss within the lifetime of the loan and includes a provision to all current loans (Stage 1 provision). The growth in the principal balance of the loan portfolio contributed approximately 1.0% to 2.0% to the Provisional Credit Loss Rate compared to the Net Credit Loss Rate. Provision for loan losses increased to $5.7 million for the nine-month period ended September 30, 2019 (2018: $3.3 million).
  • The Net Credit Loss Rate increased from 11.1% in the third quarter of 2018 to 12.6% in the third quarter of 2019. The Company expects the Net Credit Loss Rate to vary from quarter to quarter. The Net Credit Loss Rate during the nine-month period ended September 30, 2019 was 13.2%. The Company expects the Net Credit Loss Rate to average approximately 15%. The Company uses the Net Credit Loss Rate as an alternative measure to the Provisional Credit Loss Rate as it excludes the effect of provisions (reductions) in the allowance for expected credit losses during the period which may not coincide with the actual timing of charge-offs and recoveries.
  • Adjusted operating expenses increased 26.8% or $0.5 million to $2.6 million in Q3 2019 (2018: $2.1 million) due primarily to reinvestments in staff and technology, however the Adjusted Operating Expense Ratio, which is a measure of the Company’s operating efficiency, decreased to 10.1% in the third quarter of 2019 (2018: 10.5%) as the Company increased its loans under management at a greater rate than operating expenses. For the nine-month period ended September 30, 2019, adjusted operating expenses increased 23.8% to $7.4 million (2018: $6.0 million) and the Adjusted Operating Expense Ratio decreased to 9.9% in the first nine months of 2019 from 11.2% in the first nine months of 2018. Operating expenses remained relatively flat at $2.2 million for the three-month period ended September 30, 2019 compared to $2.1 million in the same period in 2018. The reinvestments in staff and technology were offset by the non-recurring gain relating to the revaluation of convertible debentures of $0.5 million in Q3 2019 following the extension of the convertible debentures from December 31, 2020 to December 31, 2023.
  • IOU closed on its third quarter ended September 30, 2019 with adjusted net earnings of $769,906 compared to adjusted net earnings of $468,659 for the third quarter ended September 30, 2018. IOU closed on the nine-month period ended September 30, 2019 with adjusted net earnings of $1,544,843, compared to adjusted net earnings of $1,791,184 for the same period last year.
  • IOU closed on its third quarter ended September 30, 2019 with IFRS net earnings of $1,000,614, or $0.01 per share, compared to IFRS net earnings of $600,593 or $0.01 per share for the same period in 2018. IOU closed on the nine-month period ended September 30, 2019 with IFRS net earnings of $1,305,740, or $0.01 per share, compared to IFRS net earnings of $2,250,580 or $0.03 per share for the same period last year.
  • Since the establishment of the NCIB on May 1, 2019, IOU repurchased for cancellation 1,222,000 common shares in the market for a total cost of $253,421.

Adjusted and IFRS net earnings

Three-Month

Nine-Month

For the period ended September 30

2019

$

2018

$

2019

$

2018

$

Interest revenue

5,165,303

3,254,520

12,663,112

9,926,771

Servicing & other income

1,634,082

1,378,742

4,752,084

3,421,113

Adjusted Gross Revenue

6,799,385

4,633,262

17,415,196

13,347,884

Interest expense

1,062,039

854,095

2,899,799

2,491,162

Provision for loan losses

2,367,101

1,327,017

5,712,484

3,323,455

Recoveries

(41,640)

(129,058)

(169,913)

(256,840)

Cost of Revenue

3,387,500

2,052,057

8,442,370

5,557,777

Adjusted Net Revenue

Adjusted operating expense

2,641,979

2,083,059

7,427,983

5,998,923

Income tax expense/(recovery)

29,487

Adjusted Net Earnings

769,906

468,659

1,544,843

1,791,184

Adjusted Net Earnings per Share

0.01

0.01

0.02

0.02

Adjusted Net Earnings

769,906

468,659

1,544,843

1,791,184

 Non-cash gain on sales of loans

734,264

1,088,475

2,356,397

2,490,685

 Non-cash amortization of servicing asset

(938,051)

(850,415)

(2,844,177)

(1,890,664)

 Non-cash stock-based compensation

(51,084)

(106,126)

(236,902)

(140,625)

 Non-recurring costs

485,579

485,579

Net Earnings per IFRS

1,000,614

600,593

1,305,740

2,250,580

Net Earnings per Share

0.01

0.01

0.01

0.03

OUTLOOK

IOU is committed to its strategy of profitable growth. IOU continues to closely monitor the performance of its loan portfolio, capture operational efficiencies and keep costs under control.  IOU is also committed to its strategy of building a resilient funding model. In line with this objective, IOU continues to maintain diversified sources of institutional capital.

The Company intends to grow loan originations by:

    • Identifying, recruiting and partnering with business loan brokers;
    • Forming new strategic partnerships with entities such as banks and small business suppliers and leveraging their relationships with small businesses to add new customers;
    • Expanding its product offering to allow it to serve small businesses whose needs are not met by its current products;
    • Investing in direct marketing and sales; and
    • Continuing its expansion into Canada.

These efforts are key to achieving the Company’s long-term outlook for loan origination growth of 25% to 30% annually.

IOU’s financial statements and management discussion & analysis for the quarter ended September 30, 2019 have been filed on SEDAR and are available at www.sedar.com.

CONFERENCE CALL

The Company will hold a conference call at 4:30 (EDT) on November 18, 2019, to discuss its financial results. The dial-in number to access the conference call from Canada and the United States is 1 (888) 231-8191 (toll-free), conference ID: 1559245

CORPORATE UPDATE

The Company also announced today changes to its board of directors (the “Board”). Serguei Kozmine tendered his resignation as a director of the Company and the Board has appointed Lucas Timberlake to fill this Board vacancy.

Lucas Timberlake has been a Partner with Fintech Ventures Fund, LLLP, a financial technology-focused investment firm, since 2015. Since assuming his current role, Mr. Timberlake has held several board director positions with technology-enabled lending companies in the small business and real estate lending sectors, and currently serves on the board of directors for GROUNDFLOOR Finance. Previously, Mr. Timberlake was part of the investment team with Antarctica Capital, an international private equity firm focusing on real assets and insurance opportunities. Mr. Timberlake began his career as an investment banking analyst with Bank of America Merrill Lynch. Mr. Timberlake holds a Bachelor of Arts in Economics and Political Science from Columbia College of Columbia University.

“We thank Mr. Kouzmine for his services to the Board over these past years, and welcome Mr. Timberlake to IOU’s Board”, said Philippe Marleau, CEO.

 

SOURCE IOU Financial Inc.

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending